Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|August 12, 2025
Impact of standardized immunophenotyping and MRD monitoring on early mortality reduction in childhood leukemia: a step towards addressing healthcare disparities in vulnerable populations from Southern MexicoLaura Alfaro-Hernández, Dalia Ramírez-Ramírez, Rubí Romo-Rodríguez, et al.
Environmental Research|September 16, 2025
Extremely low-frequency magnetic fields (ELF-MF) and radiofrequency: Risk of childhood CNS tumors in a city with elevated ELF-MF exposureVíctor Correa-Correa, Juan Carlos Núñez-Enríquez, Gabor Mezei, et al.
Frontiers in Oncology|September 25, 2023
A protective maternal nutrient concomitant intake associated with acute leukemia might be modified by sex, in children under 2 yearsÁngel Mérida-Ortega, María Luisa Pérez-Saldivar, Laura E Espinoza-Hernández, et al.
Frontiers in Oncology|January 23, 2024
Maternal diet in pregnancy and acute leukemia in infants: a case-control study in Mexico CityMaría Luisa Pérez-Saldivar, M Karen Flores-García, Nancy Núñez-Villegas, et al.
Frontiers in Nutrition|November 29, 2023
Maternal dietary patterns and acute leukemia in infants: results from a case control study in MexicoPaloma Muñoz-Aguirre, Edgar Denova-Gutiérrez, María Luisa Pérez-Saldivar, et al.
Frontiers in Oncology|April 18, 2024
Implementation of a roadmap for the comprehensive diagnosis, follow-up, and research of childhood leukemias in vulnerable regions of Mexico: results from the PRONAII StrategyJuan Carlos Núñez-Enríquez, Rubí Romo-Rodríguez, Pedro Gaspar-Mendoza, et al.
Frontiers in Oncology|April 18, 2024
<i>IKZF1</i> is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemiaJoaquin Garcia-Solorio, Juan Carlos Núñez-Enriquez, Marco Jiménez-Olivares, et al.
Frontiers in Pediatrics|June 10, 2022
Low Prevalence of <i>ETV6::RUNX1</i> Fusion Gene in a Hispanic PopulationMinerva Mata-Rocha, Angelica Rangel-López, Elva Jimenez-Hernandez, et al.
Frontiers in Oncology|November 24, 2022
NK cells with decreased expression of multiple activating receptors is a dominant phenotype in pediatric patients with acute lymphoblastic leukemiaLucero Valenzuela-Vázquez, Juan Carlos Nuñez-Enriquez, Jacqueline Sánchez-Herrera, et al.
Frontiers in Oncology|October 19, 2020
Genotype-Environment Interaction Analysis of NQO1, CYP2E1, and NAT2 Polymorphisms and the Risk of Childhood Acute Lymphoblastic Leukemia: A Report From the Mexican Interinstitutional Group for the Identification of the Causes of Childhood LeukemiaAurora Medina-Sanson, Juan Carlos Núñez-Enríquez, Eduardo Hurtado-Cordova, et al.
Pageof 6